Why the study?
Does emergent biventricular assist device placement eliminate refractory polymorphic ventricular tachycardia in a patient with giant cell myocarditis?
Population
A 55-year-old woman with giant cell myocarditis and refractory polymorphic ventricular tachycardia
Comparison
Emergent biventricular assist device placement
Design
Case report
Loading...
May support biventricular assist device consideration for refractory polymorphic VT in giant cell myocarditis; leaves open need for prospective validation.
Does emergent biventricular assist device placement eliminate refractory polymorphic ventricular tachycardia in a patient with giant cell myocarditis?
Biventricular assist device placement may be an effective emergent intervention for terminating refractory polymorphic ventricular tachycardia in patients with giant cell myocarditis.
A 2020 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: